$6.29
1.62% yesterday
Nasdaq, Aug 21, 10:08 pm CET
ISIN
US53216B1044
Symbol
LFMD

LifeMD Stock News

Neutral
GlobeNewsWire
about 4 hours ago
NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of LifeMD, Inc. (NASDAQ: LFMD) resulting from allegations that LifeMD may have issued materially misleading business information to the investing public.
Neutral
Seeking Alpha
3 days ago
LifeMD saw year-over-year revenue growth for its second quarter slow markedly from the comparable figure in the first quarter. Gross profit margins dipped 200 basis points, versus its year-ago period, as revenue guidance for 2025 was revised down. LFMD is now trading at a 1.2x price-to-sales multiple, but faces a risk from a further growth slowdown.
Neutral
GlobeNewsWire
6 days ago
NEW YORK, Aug. 16, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of LifeMD, Inc. (NASDAQ: LFMD) resulting from allegations that LifeMD may have issued materially misleading business information to the investing public.
Neutral
GlobeNewsWire
7 days ago
Investors can contact the law firm at no cost to learn more about recovering their losses
Negative
Investors Business Daily
16 days ago
LifeMD shares plummeted Wednesday after the telehealth outlet acknowledged higher customer acquisition costs hit hard in the second quarter.
Neutral
The Motley Fool
16 days ago
LifeMD (LFMD) Q2 Revenue Rises 23%
Neutral
Seeking Alpha
16 days ago
LifeMD, Inc. (NASDAQ:LFMD ) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants Justin Schreiber - Chairman & CEO Marc Benathen - Chief Financial Officer Conference Call Participants Anderson Schock - B. Riley Securities, Inc., Research Division Jenny Shen - BTIG, LLC, Research Division Ryan Robert Meyers - Lake Street Capital Markets, LLC, Research Division Sarah El...
Neutral
GlobeNewsWire
16 days ago
Total revenue increased 23% year-over-year to $62.2 million; adjusted EBITDA rose 223% to $7.1 million Telehealth revenue increased 30% to $48.6 million; telehealth adjusted EBITDA rose 560% to $3.4 million Generated more than $8 million of operating cash flow Paid down $2.1 million of senior debt, exited the quarter with $36.2 million in cash and fully repaid all remaining senior debt subseque...

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today